ACUTAAS

Acutaas Chemicals Limited

NSE
Last Traded Price
₹3470 -25.2 (-0.72%)
Open
₹3472
High
₹3535
Low
₹3450
Prev Close
₹3495.2
Industry
Pharmaceuticals
Market Cap
28409.28 Cr

Price Chart

Loading chart data...
Data delayed by up to 5 minutes. Not live.

Filing History

Recent corporate announcements and filings for ACUTAAS

Governance Neutral
2026-07-02 20:25
- Acutaas Chemicals Limited announced the promotion and designation of Mr. Anurag Shukla as General Manager Operations & Unit Head - Ankleshwar. - He is designated as a Senior Management Personnel of the company, effective July 2, 2026.
Ownership Neutral
2026-06-26 17:41
- Trading Window for Designated Persons to close from July 1, 2026, for the purpose of considering Unaudited Financial Results for the first quarter ended June 30, 2026. - The window will reopen 48 hours after the declaration of the results.
Business Update Negative
2026-06-23 11:24
CRITICAL RED FLAG DETECTED
- Acutaas Chemicals Limited announced the conclusion of an Inspection/Search by the Central Goods & Service Tax & Central Excise (CGST & CE), Anti-evasion Department, Surat, on June 23, 2026.- The company stated there is no material impact on its financials, operations, or other activities due to this inspection.
Business Update Negative
2026-06-22 21:27
CRITICAL RED FLAG DETECTED
- CGST & CE, Anti-evasion Department initiated inspection/search proceedings at the company's Sachin facility and registered office on June 22, 2026. - The proceedings are ongoing, and the company is cooperating. - Currently, there is no material impact on financials or operations.
Ownership Positive
2026-05-19 18:23
Acutaas Chemicals Limited announced on May 19, 2026, the preferential allotment of 1,111 equity shares of its subsidiary, Acutaas Chemicals Electrolytes Private Limited (ACEPL), to A.R.Z Pharma Ltd. at an issue price of Rs. 52,490/- per share. This transaction reduces Acutaas Chemicals Limited's shareholding in ACEPL from 100% to 90%, transitioning ACEPL from a wholly-owned subsidiary to a subsidiary. Management control of ACEPL remains unchanged with Acutaas Chemicals Limited.
Business Update Neutral
2026-05-14 18:17
ACUTAAS CHEMICALS LIMITED announced its schedule of investor conferences for May and June 2026. Company officials will attend the 360 ONE Capital (B&K) 16th Annual Investor Conference - Trinity India 2026 in Mumbai on May 27 & 29, and Kotak India Corporate Day events in Hongkong (June 8), Singapore (June 9 & 10), and London (June 15 & 16) to interact with investors/analysts. No price-sensitive information will be discussed.
Routine Neutral
2026-05-06 10:46
New Filing detected. See link for details.
Business Update Neutral
2026-04-30 19:19
ACUTAAS CHEMICALS LIMITED informed the stock exchanges about the availability of the recording for its Earnings Call, which was held on April 30, 2026, at 5:30 p.m. IST. The recording can be accessed on the company's website at www.acutaas.com and through a direct link provided in the filing.
Routine Neutral
2026-04-30 17:38
New Filing detected. See link for details.
Financials Positive
2026-04-30 12:40
Acutaas Chemicals Limited reported strong Q4 FY26 consolidated results. Revenue from Operations stood at ₹4,328mn vs ₹3,085mn (▲40.3% YoY), EBITDA at ₹1,835mn vs ₹850mn (▲116.0% YoY), and PAT at ₹1,343mn vs ₹627mn (▲114.1% YoY). EBITDA Margin expanded significantly to 42.4% vs 27.5% (▲1490bps). Management is confident of delivering 25% revenue growth in FY27.
Financials Positive
2026-04-30 12:25
ACUTAAS CHEMICALS LIMITED (formerly Ami Organics Limited) reported strong consolidated financial results for the quarter ended March 31, 2026. Consolidated Revenue stood at ₹432.75 Cr compared to ₹308.48 Cr in the previous year's corresponding quarter, marking a significant ▲40.26% YoY growth. EBITDA surged to ₹183.51 Cr versus ₹84.96 Cr (▲116.00% YoY), and Net Profit (PAT) increased to ₹134.28 Cr from ₹62.72 Cr (▲114.11% YoY). The company also saw a substantial EBITDA Margin expansion from 27.54% to 42.40% (▲1486 bps). Additionally, the Board recommended a final dividend of ₹2.50 per equity share (50%) for FY 2025-26.
Business Update Neutral
2026-04-27 14:31
Acutaas Chemicals Limited announced an Earnings Conference Call on April 30, 2026, at 5:30 P.M. IST, to discuss the Audited Standalone & Consolidated Financial Results for the fourth quarter and year ended March 31, 2026.
Routine Neutral
2026-04-08 12:10
New Filing detected. See link for details.
Routine Neutral
2026-04-02 18:10
Acutaas Chemicals Limited filed a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2026. The Registrar and Share Transfer Agent confirmed no dematerialisation requests were received or processed during the quarter.
Routine Neutral
2026-03-25 16:21
Acutaas Chemicals Limited announced the closure of its trading window for designated persons from April 1, 2026, for the purpose of considering the audited financial results for the fourth quarter and year ending March 31, 2026. The window will reopen 48 hours after results declaration.
Business Update Neutral
2026-03-02 12:01
Acutaas Chemicals Limited announced its officials will attend the Investec India Promoter & Founder Conference 2026 on March 11, 2026, in Mumbai. They will engage with investors/analysts in one-on-one or group meetings. No unpublished price-sensitive information will be discussed during the conference.
Business Update Neutral
2026-02-17 12:33
Acutaas Chemicals Limited announced that company officials will attend the Omkara Capital Investors Meet on February 21, 2026, and the Kotak Flagship Conference on February 24, 2026, for one-on-one/group meetings with investors and analysts. No unpublished price-sensitive information will be discussed.
Business Update Positive
2026-02-11 19:03
Acutaas Advance Material Limited, a subsidiary of Acutaas Chemicals Limited, completed the acquisition of a 75% controlling stake in Indichem Inc., a South Korean company in the Semiconductor Chemicals industry. This acquisition aligns with the company's growth strategy to expand its specialty chemicals portfolio.
Business Update Positive
2026-02-03 14:57
Acutaas Chemicals Limited Q3 FY26 Earnings Call transcript confirms strong performance. Revenue just under INR400Cr, PAT over INR100Cr, with YoY growth of 47% in Advanced Pharma and 16.5% in Specialty Chemicals. FY26 revenue growth guidance upgraded to 30%, EBITDA margin to 32-35%. New battery chemicals block inaugurated.
Business Update Neutral
2026-01-30 17:59
Acutaas Chemicals Limited officials will attend the JM Financial India Xchange Conference on February 5, 2026, in Singapore for one-on-one/group meetings with investors/analysts.
Business Update Positive
2026-01-29 18:36
Acutaas Chemicals Limited filed its Annual Sustainability Report for FY 2024-25. The company reported surpassing ₹1,000 crore in consolidated revenue and achieving the EcoVadis Platinum Medal, demonstrating strong financial and sustainability performance.
Financials Positive
2026-01-29 18:21
Consolidated Revenue ₹393.18Cr vs ₹274.99Cr (▲43.0% YoY), EBITDA ₹155.35Cr vs ₹70.34Cr (▲120.9% YoY), PAT ₹106.22Cr vs ₹45.45Cr (▲133.7% YoY). EBITDA Margin 39.5% vs 25.6% (▲1393bps).

Unlock Full History

Log in to view all historical filings for ACUTAAS and get instant Telegram alerts when new announcements drop.

Login with Telegram